Alle verbonden artikelen

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Auteurs : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Jaar : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pagina's : 21-7

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Auteurs : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Jaar : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pagina's : 14-21

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.

Auteurs : Awada A, Hendlisz A, Christensen O, Lathia CD, Bartholomeus S, Lebrun F, de Valeriola D, Brendel E, Radtke M, Delaunoit T, Piccart-Gebhart M, Gil T
Jaar : 2012
Journal : Eur. J. Cancer
Volume : 48(4)
Pagina's : 465-74

Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.

Auteurs : Azim H, Azim HA
Jaar : 2012
Journal : Future Oncol
Volume : 8(2)
Pagina's : 135-44

Clinical development of insulin-like growth factor receptor-1 (IGF-1R) inhibitors: At the crossroad?

Auteurs : Gombos A, Metzger-Filho O, Dal Lago L, Awada A
Jaar : 2012
Journal : Invest New Drugs
Volume : 30(6)
Pagina's : 2433-42

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Auteurs : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Jaar : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pagina's : 9-28

Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.

Auteurs : Antoine C, Ameye L, Paesmans M, Rozenberg S
Jaar : 2012
Journal : Maturitas
Volume : 72(4)
Pagina's : 317-23

Oncological intensive care: 2011 year's review].

Auteurs : Sculier JP, Berghmans T, Meert AP
Jaar : 2012
Journal : Rev Med Brux
Volume : 33(6)
Pagina's : 540-4

Second primary cancers in head and neck cancer patients: a challenging entity.

Auteurs : de Castro G, Awada A
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pagina's : 203-4

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

Auteurs : Van Beckhoven D, Buvé A, Ruelle J, Seyler L, Sasse A, + collaborators (among others :, Van den Wijngaert S
Jaar : 2012
Journal : Acta Clin Belg
Volume : 67(5)
Pagina's : 333-7

Urine iodide determination by ion-pair reversed-phase high performance liquid chromatography and pulsed amperometric detection.

Auteurs : Nguyen VT, Piersoel V, El Mahi T
Jaar : 2012
Journal : Talanta
Volume : 99
Pagina's : 532-7

MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.

Auteurs : Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, Najar M, Hamade E, Jebbawi F, Merimi M, Romero P, Burny A, Badran B, Martiat P
Jaar : 2012
Journal : J. Biol. Chem.
Volume : 287(13)
Pagina's : 9910-22

Clinical development of new formulations of cytotoxics in solid tumors.

Auteurs : Azim HA, Awada A
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pagina's : 325-31

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

Auteurs : Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber Rd, Bernhard J, + collaborators (among others :, Nogaret JM
Jaar : 2012
Journal : Br J Cancer
Volume : 106(10)
Pagina's : 1618-25

Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial.

Auteurs : Piccart-Gebhart M
Jaar : 2012
Journal : Ann Oncol
Volume : 23 Suppl 6
Pagina's : vi5-vi6

Chemoprevention for breast cancer.

Auteurs : Bozovic-Spasojevic I, de Azambuja E, McCaskill-Stevens W, Dinh P, Cardoso F
Jaar : 2012
Journal : Cancer Treat Rev
Volume : 38(5)
Pagina's : 329-339

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.

Auteurs : Fernández-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth KS, Quinaux E, Buyse M, Dolci MS, de Azambuja E, Hainaut P, + collaborators (among others :, Larsimont D, Piccart-Gebhart M, Olivier M
Jaar : 2012
Journal : Breast Cancer Res
Volume : 14(3)
Pagina's : R70

Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.

Auteurs : Awada A, Vandone AM, Aftimos P
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pagina's : 297-304

Radical cystectomy - pro laparoscopic].

Auteurs : Rassweiler J, Godin K, Goezen AS, Kusche D, Chlosta P, Gaboardi F, Abbou CC, Van Velthoven R
Jaar : 2012
Journal : Urologe A
Volume : 51(5)
Pagina's : 671-8

Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.

Auteurs : Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F
Jaar : 2012
Journal : Int. J. Antimicrob. Agents
Volume : 39(3)
Pagina's : 208-16